GoingToMeet

Oxford Global Conferences is proud to present both the 11th Annual Drug Discovery Leaders Summit, which is to be held on the 9th- 10th and its Pre-Conference Symposium on Open Innovation on the 8th June 2010 at Le Montreux Palace, Switzerland. The summit is the single most senior-level and focused event in Europe dedicated to the drug discovery and pharma market. Over three days, the Summit will attract over 200 senior-level decision makers working in drug discovery from the UK, Europe and US’s leading pharmaceutical, biotech, academic and research institutions. This prestigious event provides a forum for R&D and drug discovery practitioners and prominent innovators to learn more about key solutions being provided to their industry, network with their peers, and address key industry concerns through a series of cutting edge conference presentations in a professional yet relaxed environment. This meeting will also be co-located with Oxford Global’s 2nd Annual GPCR Congress.

In keeping with Oxford Global’s highly successful drug discovery series, an expert panel of speakers will present a full conference programme covering science, technology, strategy, data management and informatics, allowing attendees to gain an essential industry update. Key topics include:

R & D Strategies & Pharm/Biotech Alliances Collaborations & Outsourcing
– Strategies to enhance drug discovery, overcoming attrition, prediction tools that drive clear decisive rules, risk management.
Drug Design
– GPCR’s, RNAi, and Proteins Kinases, reducing risk of toxicity, structure based discovery, hit to lead strategies, fragment based techniques.
Screening techniques & Assay Development
– Improving quality of assays, cost effective HTS & HCS, moving towards more complex systems.
– Successful partnerships, managing alliances, balancing conflicting interests, biotech technology platforms.
Biomarkers & Translational Medicine
- Personalised medicine, decision making tools, surrogate end points, translation strategies, validation, biobanking.
Bioinformatics
- In-silico data, data mining, predictive modelling.


Who will attend?
Delegates are pre-qualified dependent on budget, responsibility and seniority. Delegates are senior-level decision makers, from major pharmaceutical and biotech companies based in Europe and typically include SVPs, VPs and Directors of:
Drug Discovery, Biomarkers, Medicinal Chemistry, Screening, Strategic Alliances, R&D, Screening ,Enabling Technologies, Genomics, Enabling Science Informatics, Toxicology, Portfolio Management, Proteomics, Structural Biology Systems Biology, Translational Medicine, Assay Development, Bioinformatics, Lead Generation/ Validation/ Optimisation